A previous study has revealed that chemotherapy-resistant HCC, such as 5-FU, increases MDSC activity, and that the use of the anti-IL-6 neutralizing antibody in combination with 5-FU significantly reduces tumor growth and can help overcome drug resistance [135]. This evidence concerns the gene IL6 and neoplasm.